Alexis Peyroles

Alexis Peyroles

Chief Executive Officer at Ose Immunotherapeutics, Inc.

Net worth: 5 M $ as of 2024-03-30

Health Technology
Consumer Services
Distribution Services

Profile

Alexis Peyroles currently works at Ose Immunotherapeutics, Inc., as Chief Executive Officer and Aperana Consulting SAS, as Chairman.
Mr. Peyroles also formerly worked at OSE Immunotherapeutics SA, as Chief Executive Officer & Director from 2018 to 2022, Guerbet Imagem do Brasil Ltda., as Chief Executive Officer, Guerbet SA, as Manager-Financial Control, Sanofi-Aventis Japan, as Head-Financial Control-Baltic States, Sanofi-Aventis France SA, as Head-Eastern Europe Business Development, and Orphan Synergy Europe-Pharma SA, as CFO & Head-Business Development.
Mr. Peyroles received his undergraduate degree from École des Hautes Études Commerciales du Nord and Masters Business Admin degree from Imperial College Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2022-12-30 929,862 ( 4.27% ) 5 M $ 2024-03-30

Alexis Peyroles active positions

CompaniesPositionStart
Aperana Consulting SAS Chairman -
Ose Immunotherapeutics, Inc. Chief Executive Officer -
All active positions of Alexis Peyroles

Former positions of Alexis Peyroles

CompaniesPositionEnd
OSE IMMUNOTHERAPEUTICS Chief Executive Officer 2022-01-15
Guerbet Imagem do Brasil Ltda. Chief Executive Officer -
Sanofi-Aventis Japan Comptroller/Controller/Auditor -
GUERBET Comptroller/Controller/Auditor -
Corporate Officer/Principal -
See the detail of Alexis Peyroles's experience

Training of Alexis Peyroles

École des Hautes Études Commerciales du Nord Undergraduate Degree
Imperial College Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alexis Peyroles's experience

Connections

20

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
GUERBET

Health Technology

OSE IMMUNOTHERAPEUTICS

Health Technology

Private companies6
Sanofi-Aventis Japan

Distribution Services

Health Technology

Aperana Consulting SAS

Ose Immunotherapeutics, Inc.

Guerbet Imagem do Brasil Ltda.

See company connections
  1. Stock Market
  2. Insiders
  3. Alexis Peyroles